CompletedNot Applicable

Impact of Cardiac Surgery With a Minimal Invasive Extracorporeal Circuit οn Coagulation: Data From Point of Care Devices

Greece57 participantsStarted 2018-12-01

Plain-language summary

This study includes patients undergoing elective cardiac surgery on MiECC. Coagulation status is assessed with ROTEM (TEM International GmbH, Munich, Germany) and Platelet function with impedance aggregometry using the ROTEM-Platelet (TEM International GmbH, Munich, Germany).

Who can participate

Age range18 Years – 79 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * elective cardiac surgery Exclusion Criteria: * unwillingness to participate * preoperative platelet count ≤150 × 109/mm3 * redo surgery * a known coagulation disorder * inaccurate documentation of preoperative anti-platelet medication.

What they're measuring

Change of Clotting Time

Timeframe: Sample 1: baseline, Sample 2: after aortic cross clamp off

Change of Maximum Clot Firmness

Timeframe: Sample 1: baseline, Sample 2: after aortic cross clamp off

Change of Clot Formation Time

Timeframe: Sample 1: baseline, Sample 2: after aortic cross clamp off

Change of ADPtest of Impedance Aggregometry

Timeframe: Sample 1: baseline, Sample 2': 20 minutes after heparin reversal

Change of TRAPtest of Impedance Aggregometry

Timeframe: Sample 1: baseline, Sample 2': 20 minutes after heparin reversal

Trial details

NCT IDNCT04159064

SponsorAHEPA University Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2019-04-30

View on ClinicalTrials.gov More Extracorporeal Circulation; Complications trials